Gene · 7555
Papers3,135
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,135
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Elevated Risk of Endometrial Cancer and Precursor Lesions in Patients With Myotonic Dystrophy: A Retrospective Study at a Single Institution in Japan. | J Obstet Gynaecol Res | 2026 | 41744896 | PubTator, text mining | PubMed |
| Nanotechnology-Driven Precision Modulation of Transplant Immunity: From Mechanistic Insights to Clinical Tolerance. | Int J Nanomedicine | 2026 | 41743232 | PubTator, text mining | PubMed |
| Obesogens in Prostate Cancer: An Endocrine and Metabolic Threat. | Curr Obes Rep | 2026 | 41739363 | PubTator, text mining | PubMed |
| Innovative strategies for diabetic peripheral neuropathy: From clinical management to emerging bioengineering solutions. | Bioact Mater | 2026 | 41737633 | PubTator, text mining | PubMed |
| Editorial: Perspectives in molecular viral pathogenesis. | Front Cell Infect Microbiol | 2026 | 41736793 | PubTator, text mining | PubMed |
| Metabolic hubs in reproduction: The regulatory network of lipid droplets in gamete and embryo physiology (Review). | Int J Mol Med | 2026 | 41716021 | PubTator, text mining | PubMed |
| Lipids in kidney diseases: from systemic imbalance to intrarenal alterations of cellular lipid metabolism in rare and common kidney diseases. | J Mol Med (Berl) | 2026 | 41714434 | PubTator, text mining | PubMed |
| Identification of enzymatically modified isoquercitrin as a therapeutic lead for myotonic dystrophy type 1. | NAR Mol Med | 2026 | 41710065 | PubTator, text mining | PubMed |
| Microbiota in cancer: current understandings and future perspectives. | Signal Transduct Target Ther | 2026 | 41629271 | PubTator, text mining | PubMed |
| Aberrant skeletal muscle morphogenesis and myofiber differentiation characterize equine myotonic dystrophy. | PLoS One | 2026 | 41610137 | PubTator, text mining | PubMed |
| Osteochondrosis and osteomalacia are distinguished by inflammatory factors and metabolites. | Medicine (Baltimore) | 2026 | 41578592 | PubTator, text mining | PubMed |
| A PNPLA3-NACC1-RIPK3 pathway mediates macrophage necroptosis and inflammation in MASLD. | Hepatol Commun | 2026 | 41564367 | PubTator, text mining | PubMed |
| Role of Oxysterol-Binding Protein Family in Cholesterol Metabolism and Cancer Progression: A Review. | Med Sci Monit | 2026 | 41560326 | PubTator, text mining | PubMed |
| Development of a comprehensive cardiovascular disease genetic risk assessment test. | Genet Med Open | 2026 | 41551008 | PubTator, text mining | PubMed |
| Emerging therapeutic strategies in muscular dystrophy: an updated review on pathogenesis and treatment advances. | Mol Biol Rep | 2026 | 41524923 | PubTator, text mining | PubMed |
| Vesicle-coupled mRNA transport and translation govern intracellular organelle networking. | EMBO Rep | 2026 | 41398320 | PubTator, text mining | PubMed |
| ERLIN1: A central regulator of protein quality control, lipid homeostasis, and cellular signaling at the endoplasmic reticulum. | Cell Signal | 2026 | 41205880 | PubTator, text mining | PubMed |
| Association of Non-Coding Repeat Expansions with Parkinson's Disease Risk: Evidence from a UK Biobank-Based Whole-Genome Sequencing Study. | Mov Disord | 2026 | 41074692 | PubTator, text mining | PubMed |
| Integrative role of CTPS cytoophidia in polyploid tissue growth and nutrient adaptation. | Insect Sci | 2026 | 40287929 | PubTator, text mining | PubMed |
| Targeted therapy for liver cancer: Current status and future directions. | Bioimpacts | 2025 | 41716515 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7555/papers?page=3